Literature DB >> 24705856

Finding new bearings: a qualitative study on the transition from inpatient to ambulatory care of patients with acute myeloid leukemia.

Rinat Nissim1, Gary Rodin, Aaron Schimmer, Mark Minden, Anne Rydall, Dora Yuen, Ashley Mischitelle, Peter Fitzgerald, Christopher Lo, Lucia Gagliese, Camilla Zimmermann.   

Abstract

PURPOSE: Treatment of adult acute myeloid leukemia (AML) is intensive, with induction treatment initiated in an inpatient setting and subsequent consolidation therapy often conducted in an outpatient setting. The purpose of the present qualitative paper is to provide insight into the experience of patients in the transition from inpatient to ambulatory care.
METHODS: Participants were 35 AML patients who were interviewed about their experience of the illness and treatment. Utilizing the grounded theory method, we describe the adjustment of participants to the transition to ambulatory care.
RESULTS: As outpatients, participants described adjusting to the intensity of ambulatory treatment and to the need to assume greater responsibility for their care. They also expressed a growing desire to understand their long-term care plan, compared to their preference to focus on the present prior to discharge, and they were struggling to construct a new sense of identity.
CONCLUSIONS: AML patients are now leaving acute care settings sicker and earlier. Considering their perceptions can inform interventions to facilitate adjustment during the transition to outpatient care.

Entities:  

Mesh:

Year:  2014        PMID: 24705856     DOI: 10.1007/s00520-014-2230-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  24 in total

1.  Caught by an acute leukaemia: facing patients' own experiences.

Authors:  Michael Koehler; Thomas Fischer; Joerg Frommer
Journal:  Leuk Res       Date:  2013-03-05       Impact factor: 3.156

2.  Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.

Authors:  Lalit Saini; Mark D Minden; Andre C Schuh; Karen W L Yee; Aaron D Schimmer; Vikas Gupta; Eshetu G Atenafu; Cindy Murray; Shannon Nixon; Joseph M Brandwein
Journal:  Am J Hematol       Date:  2011-12-27       Impact factor: 10.047

3.  The crisis of stroke: experiences of patients and their family caregivers.

Authors:  Barbara J Lutz; Mary Ellen Young; Kim J Cox; Crystal Martz; Kerry Rae Creasy
Journal:  Top Stroke Rehabil       Date:  2011 Nov-Dec       Impact factor: 2.119

4.  Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs.

Authors:  Lewin Eisele; Florian Günther; Peter Ebeling; Jens Nabring; Ulrich Dührsen; Jan Dürig
Journal:  Onkologie       Date:  2010-11-26

5.  Evolving information priorities of hematologic cancer survivors, caregivers, and other relatives.

Authors:  Ted Gansler; James Kepner; Erika Willacy; Cindy Soloe; Douglas Rupert; Meredith Jarblum; David Driscoll; Alex Orr; Tania Fitzgerald; Angelina Esparza
Journal:  J Cancer Educ       Date:  2010-09       Impact factor: 2.037

6.  Facing mortality: a qualitative in-depth interview study on illness perception, lay theories and coping strategies of adult patients with acute leukemia 1 week after diagnosis.

Authors:  Michael Koenigsmann; Katharina Koehler; Andreas Regner; Astrid Franke; Jörg Frommer
Journal:  Leuk Res       Date:  2006-02-03       Impact factor: 3.156

7.  Abducted by the illness: a qualitative study of traumatic stress in individuals with acute leukemia.

Authors:  Rinat Nissim; Camilla Zimmermann; Mark Minden; Anne Rydall; Dora Yuen; Ashley Mischitelle; Lucia Gagliese; Aaron Schimmer; Gary Rodin
Journal:  Leuk Res       Date:  2013-01-24       Impact factor: 3.156

Review 8.  A qualitative meta-synthesis of patients' experiences of intra- and inter-hospital transitions.

Authors:  Lisbeth Uhrenfeldt; Hanne Aagaard; Elisabeth O C Hall; Liv Fegran; Mette Spliid Ludvigsen; Gabriele Meyer
Journal:  J Adv Nurs       Date:  2013-03-20       Impact factor: 3.187

Review 9.  Patients' and relatives' experiences of transfer from intensive care unit to wards.

Authors:  James P Cullinane; Catherine I Plowright
Journal:  Nurs Crit Care       Date:  2013-08-22       Impact factor: 2.325

10.  Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia.

Authors:  T Yogaparan; A Panju; M Minden; J Brandwein; H Z Mohamedali; S M H Alibhai
Journal:  Leuk Res       Date:  2009-01-22       Impact factor: 3.156

View more
  5 in total

1.  Transition journey from hospital to home in patients with cancer and their caregivers: a qualitative study.

Authors:  Wei How Darryl Ang; Siew Ping Lang; Emily Ang; Violeta Lopez
Journal:  Support Care Cancer       Date:  2016-05-13       Impact factor: 3.603

2.  Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.

Authors:  Jaein Seo; B Douglas Smith; Elihu Estey; Ernest Voyard; Bernadette O' Donoghue; John F P Bridges
Journal:  Curr Med Res Opin       Date:  2018-04-27       Impact factor: 2.580

3.  Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.

Authors:  Rebecca Crawford; Kate Sully; Rebecca Conroy; Chloe Johnson; Lynda Doward; Timothy Bell; Verna Welch; Francois Peloquin; Adam Gater
Journal:  Patient       Date:  2020-02       Impact factor: 3.883

4.  Outpatient management of intensively treated acute leukemia patients--the patients' perspective.

Authors:  Lene Østergaard Jepsen; Mette Terp Høybye; Dorte Gilså Hansen; Claus Werenberg Marcher; Lone Smidstrup Friis
Journal:  Support Care Cancer       Date:  2015-11-09       Impact factor: 3.359

5.  Keep your mind off negative things: coping with long-term effects of acute myeloid leukemia (AML).

Authors:  Vida Ghodraty-Jabloo; Shabbir M H Alibhai; Henriette Breunis; Martine T E Puts
Journal:  Support Care Cancer       Date:  2015-11-05       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.